Tonix Pharmaceuticals Holding (TNXP) Non-Current Assets (2010 - 2026)

Tonix Pharmaceuticals Holding's Non-Current Assets history runs 17 years deep, the most recent figure standing at $50.7 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 17.2% year-over-year to $50.7 million in Q1 2026; TTM through Mar 2026 was $187.2 million, a 5.99% increase from a year earlier, with the FY2025 full-year figure at $48.3 million, up 10.04% from the prior year.
• Non-Current Assets grew to $50.7 million in Q1 2026 per TNXP's latest filing, from $48.3 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $108.4 million in Q2 2023 and bottomed at $43.3 million in Q1 2025.
• The 5-year median for Non-Current Assets is $70.7 million (2022), against an average of $72.3 million.
• Across the five-year window, Non-Current Assets soared 609.63% in 2022 and tumbled 58.86% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $94.9 million in 2022, then increased by 12.41% to $106.7 million in 2023, then tumbled by 58.86% to $43.9 million in 2024, then grew by 10.04% to $48.3 million in 2025, then climbed by 5.07% to $50.7 million in 2026.
• Per Business Quant, the three latest TNXP Non-Current Assets figures stand at $50.7 million (Q1 2026), $48.3 million (Q4 2025), and $44.4 million (Q3 2025).